Friday, October 9, 2026
Home Authors Posts by Ogkologos

Ogkologos

4363 POSTS 0 COMMENTS

NECTIN4 Amplification Predicts Response to Enfortumab Vedotin and Long-Term Survival in...

Ogkologos -
0

Datopotamab Deruxtecan Shows Promising Activity in Heavily Pretreated Advanced HR-positive/HER2-negative and...

Ogkologos -
0

EMA Recommends Extension of Indications for Amivantamab

Ogkologos -
0

FDA Approves Trastuzumab Deruxtecan for Any HER2-Positive Solid Cancer

Ogkologos -
0

Nivolumab Achieves High ORR and Durable PFS in Patients with dMMR/MSI-H...

Ogkologos -
0

FDA Grants Accelerated Approval to Tovorafenib for Patients with Relapsed or...

Ogkologos -
0

Q&A: Learning About the Cancer Care Challenges LGBTQ+ People Face

Ogkologos -
0

LGBTQ+ Voices: Listening to Sexual and Gender Minority People Affected by...

Ogkologos -
0

Consistent Efficacy Benefit with Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Patients...

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Capivasertib

Ogkologos -
0
1...808182...437Page 81 of 437

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com